These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20447885)

  • 21. Elevated CD14++CD16- monocytes predict cardiovascular events.
    Berg KE; Ljungcrantz I; Andersson L; Bryngelsson C; Hedblad B; Fredrikson GN; Nilsson J; Björkbacka H
    Circ Cardiovasc Genet; 2012 Feb; 5(1):122-31. PubMed ID: 22238190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
    Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
    Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
    Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
    Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
    Rogacev KS; Zawada AM; Emrich I; Seiler S; Böhm M; Fliser D; Woollard KJ; Heine GH
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2120-7. PubMed ID: 25060791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
    Burbano C; Vasquez G; Rojas M
    Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets.
    Nockher WA; Wiemer J; Scherberich JE
    Clin Exp Immunol; 2001 Jan; 123(1):49-55. PubMed ID: 11167997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10.
    Skrzeczyńska-Moncznik J; Bzowska M; Loseke S; Grage-Griebenow E; Zembala M; Pryjma J
    Scand J Immunol; 2008 Feb; 67(2):152-9. PubMed ID: 18201370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of Monocyte Derived Dendritic Cells in End Stage Renal Disease is Skewed Towards Accelerated Maturation.
    Dopheide JF; Zeller GC; Kuhlmann M; Girndt M; Sester M; Sester U
    Adv Clin Exp Med; 2015; 24(2):257-66. PubMed ID: 25931358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor response of CD14+/CD16+ monocyte subpopulation.
    Szaflarska A; Baj-Krzyworzeka M; Siedlar M; Weglarczyk K; Ruggiero I; Hajto B; Zembala M
    Exp Hematol; 2004 Aug; 32(8):748-55. PubMed ID: 15308326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein.
    Fiedler R; Neugebauer F; Ulrich C; Wienke A; Gromann C; Storr M; Böhler T; Seibert E; Girndt M
    Artif Organs; 2012 Oct; 36(10):886-93. PubMed ID: 22845695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity.
    Merino A; Buendia P; Martin-Malo A; Aljama P; Ramirez R; Carracedo J
    J Immunol; 2011 Feb; 186(3):1809-15. PubMed ID: 21191073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD14++ CD16+ HLA-DR+ Monocytes in Peripheral Blood are Quantitatively Correlated with the Severity of Pre-eclampsia.
    Tang MX; Zhang YH; Hu L; Kwak-Kim J; Liao AH
    Am J Reprod Immunol; 2015 Aug; 74(2):116-22. PubMed ID: 25850575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease.
    Ulrich C; Heine GH; Seibert E; Fliser D; Girndt M
    Nephrol Dial Transplant; 2010 Jul; 25(7):2265-72. PubMed ID: 20150168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD16⁺ monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunction.
    Boersema M; van den Born JC; van Ark J; Harms G; Seelen MA; van Dijk MC; van Goor H; Navis GJ; Popa ER; Hillebrands JL
    Immunobiology; 2015 May; 220(5):673-83. PubMed ID: 25476849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?
    Timmerman KL; Flynn MG; Coen PM; Markofski MM; Pence BD
    J Leukoc Biol; 2008 Nov; 84(5):1271-8. PubMed ID: 18664531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expansion and differentiation of CD14+CD16(-) and CD14+ +CD16+ human monocyte subsets from cord blood CD34+ hematopoietic progenitors.
    Stec M; Weglarczyk K; Baran J; Zuba E; Mytar B; Pryjma J; Zembala M
    J Leukoc Biol; 2007 Sep; 82(3):594-602. PubMed ID: 17595380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
    Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
    Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis.
    Nockher WA; Scherberich JE
    Infect Immun; 1998 Jun; 66(6):2782-90. PubMed ID: 9596748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.